Latest & greatest articles for urinary tract infection

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on urinary tract infection or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on urinary tract infection and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for urinary tract infection

101. A 5-day antibiotic course for treatment of intermittent catheter-associated urinary tract infection in patients with spinal cord injury Full Text available with Trip Pro

A 5-day antibiotic course for treatment of intermittent catheter-associated urinary tract infection in patients with spinal cord injury This was a retrospective monocentric study conducted at Centre Calvé, France, with the objective of evaluating the effectiveness of a 5-day course of antibiotics for symptomatic (mild urinary tract infection, UTI) or asymptomatic (aBact) bacteriuria in patients with spinal cord injury on intermittent catheterization.This study was conducted from May 2013

2017 Spinal cord series and cases

102. Outcomes of ureteroscopy for patients with renal stones and clearance of infection in patients with recurrent urinary tract infections following treatment of their renal stones

Outcomes of ureteroscopy for patients with renal stones and clearance of infection in patients with recurrent urinary tract infections following treatment of their renal stones Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2017 PROSPERO

103. Vaccines for the prevention of recurrent urinary tract infections

Vaccines for the prevention of recurrent urinary tract infections Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect measures

2017 PROSPERO

104. Long-term efficacy of antibiotic prophylaxis for preventing recurrent uncomplicated urinary tract infections: a systematic review and meta-analysisÿÿ

Long-term efficacy of antibiotic prophylaxis for preventing recurrent uncomplicated urinary tract infections: a systematic review and meta-analysisÿÿ Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2017 PROSPERO

105. Prevention and Treatment of Urinary Tract Infections in Patients with Spina Bifida and Cerebral Palsy

Prevention and Treatment of Urinary Tract Infections in Patients with Spina Bifida and Cerebral Palsy Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web

2017 PROSPERO

106. Efficacy of non-carbapenems - with in vitro activity against extended spectrum beta-lactamase producing enterobacteriaceae versus carbapenems for complicated urinary tract infections: protocol for a systematic review

Efficacy of non-carbapenems - with in vitro activity against extended spectrum beta-lactamase producing enterobacteriaceae versus carbapenems for complicated urinary tract infections: protocol for a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated

2017 PROSPERO

107. To determine the antibiotic-induced changes in gut microbiota for the most commonly prescribed antibiotics in primary care in the UK for respiratory and urinary tract infections

To determine the antibiotic-induced changes in gut microbiota for the most commonly prescribed antibiotics in primary care in the UK for respiratory and urinary tract infections Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2017 PROSPERO

108. A systematic review protocol: effectiveness of catheter insertion techniques for preventing urinary tract infections following urinary catheter insertion in pediatric patients - a review of quantitative evidence

A systematic review protocol: effectiveness of catheter insertion techniques for preventing urinary tract infections following urinary catheter insertion in pediatric patients - a review of quantitative evidence Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated

2017 PROSPERO

109. A systematic review of the effectiveness of interventions at reducing symptomatic urinary tract infections and E.coli bacteraemia in care home settings

A systematic review of the effectiveness of interventions at reducing symptomatic urinary tract infections and E.coli bacteraemia in care home settings Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2017 PROSPERO

118. Uncomplicated urinary tract infection (UTI) (pyelonephritis and cystitis)

Uncomplicated urinary tract infection (UTI) (pyelonephritis and cystitis)

2017 DynaMed Plus

119. Plazomicin (Zemdri) - To treat adults with complicated urinary tract infections

Plazomicin (Zemdri) - To treat adults with complicated urinary tract infections Drug Approval Package: ZEMDRI (plazomicin) U.S. Department of Health and Human Services Search FDA Submit search Drug Approval Package: ZEMDRI (plazomicin) Company: Achaogen, Inc. Application Number: 210303 Orig 1 Approval Date: 07/27/2018 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. FDA Approval Letter and Labeling (PDF) (PDF) FDA Application Review

2017 FDA - Drug Approval Package

120. A systematic review and network meta-analysis of randomized controlled trials for treatment of acute uncomplicated urinary tract infection in women -- review in Urinary Tract Infection Care-1 (RUsTIC-1)

A systematic review and network meta-analysis of randomized controlled trials for treatment of acute uncomplicated urinary tract infection in women -- review in Urinary Tract Infection Care-1 (RUsTIC-1) Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files

2017 PROSPERO